Home
MRK
MRK News

Latest Merck & Company Inc. (new) (MRK) News on November 25, 2024

Hedge Funds Bet Big On Merck & Co. (MRK): Top Healthcare Stock to Watch

Insider Monkey

a day ago

Hedge Funds Bet Big On Merck & Co. (MRK): Top Healthcare Stock to Watch

U.S. FDA found asthma drug Singular, montelukast impacts the brain, Reuters says

TipRanks

2 days ago

U.S. FDA found asthma drug Singular, montelukast impacts the brain, Reuters says

Merck Recommends Rejection of TRC Capital’s "Mini-Tender" Offer

Business Wire

2 days ago

Merck Recommends Rejection of TRC Capital’s "Mini-Tender" Offer

Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know

Zacks

3 days ago

Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know

Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Business Wire

3 days ago

Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Merck’s WELIREG® (belzutifan) Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors

Business Wire

3 days ago

Merck’s WELIREG® (belzutifan) Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors

Surendralal Karsanbhai Elected to Merck Board of Directors

Business Wire

3 days ago

Surendralal Karsanbhai Elected to Merck Board of Directors

Goldman Sachs: Merck & Co., Inc. (MRK) Is A Top Growth Investor Stock

Insider Monkey

3 days ago

Goldman Sachs: Merck & Co., Inc. (MRK) Is A Top Growth Investor Stock

Top US Dividend Stocks To Consider In November 2024

Simply Wall St.

3 days ago

Top US Dividend Stocks To Consider In November 2024

Exclusive-US FDA finds widely used asthma drug impacts the brain

Reuters

3 days ago

Exclusive-US FDA finds widely used asthma drug impacts the brain

Top Analyst Reports for Broadcom, Merck & Qualcomm

Zacks

3 days ago

Top Analyst Reports for Broadcom, Merck & Qualcomm

Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities

Business Wire

4 days ago

Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities

Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals

Pharma Voice

4 days ago

Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals

Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care

ACCESSWIRE

4 days ago

Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care

Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio

Insider Monkey

4 days ago

Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio

MT Newswires

5 days ago

CFRA Upgrades Merck to Buy

Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients

Benzinga

5 days ago

Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients

Merck Announces First-Quarter 2025 Dividend

Business Wire

5 days ago

Merck Announces First-Quarter 2025 Dividend

Under-the-skin Keytruda comparable to infused version in Phase 3 study, Merck says

BioPharma Dive

6 days ago

Under-the-skin Keytruda comparable to infused version in Phase 3 study, Merck says

Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints

Business Wire

6 days ago

Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints

Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’

Insider Monkey

6 days ago

Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’

Is Merck & Co., Inc. (MRK) the Best Immunotherapy Stock to Buy Now?

Insider Monkey

7 days ago

Is Merck & Co., Inc. (MRK) the Best Immunotherapy Stock to Buy Now?

Why Merck rolled the dice on an ‘unbelievable’ early-stage brain cancer drug

Pharma Voice

7 days ago

Why Merck rolled the dice on an ‘unbelievable’ early-stage brain cancer drug

Morningstar Research

7 days ago

Analyst Report: Merck & Co., Inc.

How analysts are reacting to RFK Jr. as Trump's HHS pick

Yahoo Finance Video

9 days ago

How analysts are reacting to RFK Jr. as Trump's HHS pick

Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy

Zacks

9 days ago

Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy

The Strong Earnings Posted By Merck (NYSE:MRK) Are A Good Indication Of The Strength Of The Business

Simply Wall St.

9 days ago

The Strong Earnings Posted By Merck (NYSE:MRK) Are A Good Indication Of The Strength Of The Business

Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.

Yahoo Finance

10 days ago

Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Non-Epithelioid Malignant Pleural Mesothelioma (MPM)

Business Wire

10 days ago

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Non-Epithelioid Malignant Pleural Mesothelioma (MPM)

Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics

Investor's Business Daily

10 days ago

Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics

Merck to Participate in the Jefferies London Healthcare Conference

Business Wire

11 days ago

Merck to Participate in the Jefferies London Healthcare Conference

Merck Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines Ltd.

Business Wire

11 days ago

Merck Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines Ltd.

Merck, facing threat to Keytruda, buys into new kind of cancer immunotherapy

BioPharma Dive

11 days ago

Merck, facing threat to Keytruda, buys into new kind of cancer immunotherapy

Merck and AstraZeneca announce results of Koselugo in neurofibromatosis trial

TipRanks

12 days ago

Merck and AstraZeneca announce results of Koselugo in neurofibromatosis trial

MSD and AstraZeneca report positive topline data from Koselugo trial for NF1

Clinical Trials Arena

12 days ago

MSD and AstraZeneca report positive topline data from Koselugo trial for NF1

MT Newswires

12 days ago

Argus Cuts Price Target on Merck to $125 From $140

Argus Research

12 days ago

Analyst Report: Merck & Co Inc

Argus Research

12 days ago

Market Update: CB, CMG, MCK, MRK, VSH

With 79% ownership, Merck & Co., Inc. (NYSE:MRK) boasts of strong institutional backing

Simply Wall St.

13 days ago

With 79% ownership, Merck & Co., Inc. (NYSE:MRK) boasts of strong institutional backing

KOSELUGO® (selumetinib) Showed Significant and Clinically Meaningful Improvement in Objective Response Rate Versus Placebo in Adults With Neurofibromatosis Type 1 who Have Symptomatic, Inoperable Plexiform Neurofibromas in Global Phase 3 KOMET Trial

Business Wire

13 days ago

KOSELUGO® (selumetinib) Showed Significant and Clinically Meaningful Improvement in Objective Response Rate Versus Placebo in Adults With Neurofibromatosis Type 1 who Have Symptomatic, Inoperable Plexiform Neurofibromas in Global Phase 3 KOMET Trial

Merck to Present New Data From GARDASIL®9 Studies Reinforcing the Importance of Gender-Neutral HPV Vaccination in Adults Up to Age 45 at the International Papillomavirus Conference (IPVC) 2024

Business Wire

13 days ago

Merck to Present New Data From GARDASIL®9 Studies Reinforcing the Importance of Gender-Neutral HPV Vaccination in Adults Up to Age 45 at the International Papillomavirus Conference (IPVC) 2024

MT Newswires

14 days ago

Daiwa Securities Downgrades Merck to Neutral From Outperform, Adjusts Price Target to $100 From $130

Merck & Co., Inc. (MRK): Among the Best Low Volatility Stocks to Invest In Now

Insider Monkey

15 days ago

Merck & Co., Inc. (MRK): Among the Best Low Volatility Stocks to Invest In Now

Canada's Drug Agency Recommends WINREVAIR® (sotatercept) for Reimbursement

CNW Group

16 days ago

Canada's Drug Agency Recommends WINREVAIR® (sotatercept) for Reimbursement

Why WEC Energy, Merck And Regions Financial Are Winners For Passive Income

Benzinga

16 days ago

Why WEC Energy, Merck And Regions Financial Are Winners For Passive Income

Morningstar Research

17 days ago

Analyst Report: Merck & Co., Inc.

Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock

Zacks

17 days ago

Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock

Merck & Co., Inc. (MRK) Makes It On UBS’ List Of Stocks For The AI, Growth & Low Rates Era

Insider Monkey

17 days ago

Merck & Co., Inc. (MRK) Makes It On UBS’ List Of Stocks For The AI, Growth & Low Rates Era

MT Newswires

19 days ago

Deutsche Bank Cuts Merck Price Target to $140 From $145, Maintains Buy Rating

Merck to Participate in the UBS Global Healthcare Conference

Business Wire

19 days ago

Merck to Participate in the UBS Global Healthcare Conference

Merck Insiders Sold US$11m Of Shares Suggesting Hesitancy

Simply Wall St.

20 days ago

Merck Insiders Sold US$11m Of Shares Suggesting Hesitancy

Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy Right Now?

Insider Monkey

20 days ago

Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy Right Now?

Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease

Benzinga

23 days ago

Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease

MT Newswires

24 days ago

Wells Fargo Adjusts Merck & Co.'s Price Target to $110 From $125

MT Newswires

24 days ago

BMO Capital Adjusts Merck & Co.'s Price Target to $136 From $150

MT Newswires

24 days ago

Morgan Stanley Adjusts Merck & Co.'s Price Target to $123 From $130

MT Newswires

24 days ago

Goldman Sachs Adjusts Merck & Co.'s Price Target to $135 From $139

Merck Third Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.

24 days ago

Merck Third Quarter 2024 Earnings: EPS Misses Expectations

Merck & Co Inc (MRK) Q3 2024 Earnings Call Highlights: Strong Oncology and Animal Health ...

GuruFocus.com

24 days ago

Merck & Co Inc (MRK) Q3 2024 Earnings Call Highlights: Strong Oncology and Animal Health ...

Thomson Reuters StreetEvents

24 days ago

Q3 2024 Merck & Co Inc Earnings Call

Merck Spooks Investors With A Guidance Cut In The Wake Of Light Diabetes, HPV Shot Sales

Investor's Business Daily

24 days ago

Merck Spooks Investors With A Guidance Cut In The Wake Of Light Diabetes, HPV Shot Sales

Morningstar Research

24 days ago

Analyst Report: Merck & Co., Inc.

Merck (MRK) Q3 2024 Earnings Call Transcript

Motley Fool

24 days ago

Merck (MRK) Q3 2024 Earnings Call Transcript

Merck Q3 Earnings & Sales Top, Stock Down on Lowered '24 View

Zacks

24 days ago

Merck Q3 Earnings & Sales Top, Stock Down on Lowered '24 View

Bristol Myers Squibb stock rises, Merck moves lower. Here's why.

Yahoo Finance Video

25 days ago

Bristol Myers Squibb stock rises, Merck moves lower. Here's why.

Investing.com

25 days ago

Merck earnings top estimates amid solid demand for Keytruda cancer drug

Associated Press Finance

25 days ago

Merck: Q3 Earnings Snapshot

Merck sees Gardasil China woes carrying into 2025

Reuters

25 days ago

Merck sees Gardasil China woes carrying into 2025

Will Merck's Guidance Cut Prove Gruesome In The Wake Of Januvia, Gardasil Misses?

Investor's Business Daily

25 days ago

Will Merck's Guidance Cut Prove Gruesome In The Wake Of Januvia, Gardasil Misses?

Merck Announces Third-Quarter 2024 Financial Results

Business Wire

25 days ago

Merck Announces Third-Quarter 2024 Financial Results

Merck & Co., Inc. (MRK): A Bull Case Theory

Insider Monkey

25 days ago

Merck & Co., Inc. (MRK): A Bull Case Theory

Exelixis Beats on Q3 Earnings and Sales, Raises Annual Outlook

Zacks

a month ago

Exelixis Beats on Q3 Earnings and Sales, Raises Annual Outlook

Jim Cramer Thinks That Merck & Co., Inc. (MRK) Is ‘Too Low’

Insider Monkey

a month ago

Jim Cramer Thinks That Merck & Co., Inc. (MRK) Is ‘Too Low’

Why Is Moderna Stock Trading Higher On Monday?

Benzinga

a month ago

Why Is Moderna Stock Trading Higher On Monday?

Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?

Zacks

a month ago

Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

Business Wire

a month ago

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

Merck & Co., Inc. (MRK): Among the Best Dow Stocks to Buy According to Analysts

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): Among the Best Dow Stocks to Buy According to Analysts

Merck & Co., Inc. (MRK): Among the Best Stocks to Buy for High Returns in 2024

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): Among the Best Stocks to Buy for High Returns in 2024

Morningstar Research

a month ago

Analyst Report: Merck & Co., Inc.

Merck to Report Q3 Earnings: To Buy or Not to Buy MRK Stock?

Zacks

a month ago

Merck to Report Q3 Earnings: To Buy or Not to Buy MRK Stock?

CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines

Benzinga

a month ago

CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines

US CDC AdCom recommends lowering the age for pneumococcal vaccines

Pharmaceutical Technology

a month ago

US CDC AdCom recommends lowering the age for pneumococcal vaccines

Merck (MRK): Patent Concerns and Earnings Forecast Cuts Impact Dow Performance

Insider Monkey

a month ago

Merck (MRK): Patent Concerns and Earnings Forecast Cuts Impact Dow Performance

Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for

Zacks

a month ago

Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers

Business Wire

a month ago

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers

CDC’S ACIP Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older

Business Wire

a month ago

CDC’S ACIP Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older

800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio

Benzinga

a month ago

800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio

Is Merck & Co., Inc. (NYSE:MRK) the Most Undervalued Value Stock to Buy According to Analysts?

Insider Monkey

a month ago

Is Merck & Co., Inc. (NYSE:MRK) the Most Undervalued Value Stock to Buy According to Analysts?

Merck acquires cancer drug startup; Elevidys ex-US sales rise

BioPharma Dive

a month ago

Merck acquires cancer drug startup; Elevidys ex-US sales rise

Merck (MRK) Advances While Market Declines: Some Information for Investors

Zacks

a month ago

Merck (MRK) Advances While Market Declines: Some Information for Investors

The Zacks Analyst Blog Highlights Visa, Netflix, Merck and Hovnanian

Zacks

a month ago

The Zacks Analyst Blog Highlights Visa, Netflix, Merck and Hovnanian

Top Research Reports for Visa, Netflix & Merck

Zacks

a month ago

Top Research Reports for Visa, Netflix & Merck

Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks

Benzinga

a month ago

Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks

MT Newswires

a month ago

Goldman Sachs Adjusts Price Target on Merck to $139 From $140

Merck & Co. Inc. (MRK): Among the Best US Stocks for Foreign Investors Right Now

Insider Monkey

a month ago

Merck & Co. Inc. (MRK): Among the Best US Stocks for Foreign Investors Right Now

Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48

Business Wire

a month ago

Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48

Goldman Sachs: Merck & Co., Inc. (NYSE:MRK) Is A Stock With High Consensus ROE

Insider Monkey

a month ago

Goldman Sachs: Merck & Co., Inc. (NYSE:MRK) Is A Stock With High Consensus ROE

MSD mulls 2025/26 launch for RSV vaccine after Phase II/III win

Pharmaceutical Technology

a month ago

MSD mulls 2025/26 launch for RSV vaccine after Phase II/III win

Merck & Co. (MRK): Strong Growth Driven by Keytruda and New Vaccine Approvals

Insider Monkey

a month ago

Merck & Co. (MRK): Strong Growth Driven by Keytruda and New Vaccine Approvals

Share on Social Networks: